Up 20%: Time to Buy Amicus Therapeutics, Inc?

In biotech, when you hear that a drug's peak sales estimates hover around $200 million, usually you shrug. But for a stock like Amicus Therapeutics  (NASDAQ: FOLD  ) , with a market cap of under $300 million, suddenly $200 million in potential sales looks like a big deal.

Amicus announced yesterday that it would be reporting data from its phase 3 study (titled "Study 012") for Migalast HCL for Fabry Disease sometime in third quarter. And today shareholders got even better news, as analysts moved their price targets on the stock, reflecting increasing market optimism that this drug will perform well.

But is the stock a good investment? In the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their two cents on Amicus.

Leaked: This coming blockbuster will make even Amicus jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 3015248, ~/Articles/ArticleHandler.aspx, 7/28/2014 4:42:55 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,982.59 22.02 0.13%
S&P 500 1,978.91 0.57 0.03%
NASD 4,444.91 -4.66 -0.10%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/28/2014 3:59 PM
FOLD $4.48 Up +0.03 +0.67%
Amicus Therapeutic… CAPS Rating: **

Advertisement